Predictive Value of the Hematopoietic Stem Cell Transplantation - Comorbidity Index for Overall Survival in Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive Value of the Hematopoietic Stem Cell Transplantation - Comorbidity Index for Overall Survival in Patients with Multiple Myeloma

Published:2022-11-01 Issue:5 Volume:60 Page:468-475
ISSN:1302-0072
Container-title:Medical Bulletin of Haseki
language:
Short-container-title:Haseki

Author:

Elibol Tayfun^ORCID,Kara Osman^ORCID

Publisher

Galenos Yayinevi

Subject

General Medicine

Reference11 articles.

1. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma;Child;N Engl J Med,2003

2. non-transplant therapy in patients 70 years and older with multiple myeloma;Lemieux;Bone Marrow Transplantation,2021

3. Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years;Bashir;Leuk Lymphoma,2019

4. Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation;Sorror;J Clin Oncol,2014

5. 5. Saad A, Mahindra A, Zhang MJ, et al. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biol Blood Marrow Transplant 2014;20:402-8.e1.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3